Comparison of susceptibility to extended-spectrum β-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units
- 31 July 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 22 (3), 285-291
- https://doi.org/10.1016/0732-8893(95)00096-s
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antimicrobial activity of cefepime tested against bush group I β-lactamase-producing strains resistant to ceftazidime a multilaboratory national and international clinical isolate studyDiagnostic Microbiology and Infectious Disease, 1994
- Cefepime: overview of activity in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1993
- In-vitro antibacterial activity of cefepime: a multicentre studyJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 1993
- Prevalence of resistance of aerobic Gram-negative bacilli to broad-spectrum antibacterial agents results of a multicentre studyJournal of Antimicrobial Chemotherapy, 1990
- Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsAntimicrobial Agents and Chemotherapy, 1989
- In-vitro studies of meropenemJournal of Antimicrobial Chemotherapy, 1989
- In-vitro activity of meropenem against clinical isolates obtained in CanadaJournal of Antimicrobial Chemotherapy, 1989
- Comparative in-vitro activity of meropenem on clinical isolates from the United KingdomJournal of Antimicrobial Chemotherapy, 1989
- Clinical consequences of development of resistance to third generation cephalosporinsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987